Evoke plc (LON:EVOK – Get Free Report)’s stock price dropped 10% during trading on Thursday . The stock traded as low as GBX 50.20 ($0.65) and last traded at GBX 51.73 ($0.67). Approximately 65,066,164 shares were traded during trading, an increase of 1,994% from the average daily volume of 3,107,171 shares. The stock had previously closed at GBX 57.45 ($0.74).
Analysts Set New Price Targets
A number of equities analysts have weighed in on EVOK shares. Berenberg Bank decreased their price target on Evoke from GBX 130 ($1.68) to GBX 90 ($1.16) and set a “buy” rating for the company in a report on Wednesday, December 4th. Jefferies Financial Group restated a “buy” rating and issued a GBX 140 ($1.81) target price on shares of Evoke in a research note on Monday, December 16th.
Get Our Latest Report on Evoke
Evoke Price Performance
Evoke (LON:EVOK – Get Free Report) last released its earnings results on Wednesday, March 26th. The company reported GBX (6.40) (($0.08)) EPS for the quarter. Evoke had a negative net margin of 8.50% and a negative return on equity of 517.98%. On average, equities research analysts expect that Evoke plc will post 12.7648305 EPS for the current year.
Insider Buying and Selling at Evoke
In other news, insider Andrea Gisle Joosen acquired 14,572 shares of Evoke stock in a transaction that occurred on Tuesday, January 28th. The shares were purchased at an average cost of GBX 70 ($0.91) per share, for a total transaction of £10,200.40 ($13,202.69). 27.00% of the stock is currently owned by insiders.
Evoke Company Profile
Recommended Stories
- Five stocks we like better than Evoke
- Options Trading – Understanding Strike Price
- MarketBeat Week in Review – 03/24 – 03/28
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Should You Buy UPS Stock Now? Deep Dive Into Its 5-Year Low
- Conference Calls and Individual Investors
- 4 Healthcare Stocks With Massive Gains—and More to Come
Receive News & Ratings for Evoke Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evoke and related companies with MarketBeat.com's FREE daily email newsletter.